The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Neurological Disease Model Chip Market Research Report 2025

Global Neurological Disease Model Chip Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1981932

No of Pages : 96

Ask Your Query
Synopsis
The neurological disease model chip is a biological simulation technology specifically used to simulate the pathogenesis and drug treatment effects of specific neurological diseases. This technology is usually implemented on a microfluidic chip or a microbial chip, and artificially cultured nerve cells or tissues are planted on the chip through tissue engineering and biotechnology means. Nervous disease model chips can be used to study a variety of neurological diseases, such as Parkinson's disease, Alzheimer's disease, epilepsy, stroke, etc. By simulating disease-related physiological and pathological processes as well as the effects of drugs on diseases, researchers can better understand the pathogenesis of neurological diseases and evaluate the efficacy and safety of potential treatments and drugs.
The global Neurological Disease Model Chip market was valued at US$ 50.7 million in 2023 and is anticipated to reach US$ 87.3 million by 2030, witnessing a CAGR of 8.1% during the forecast period 2024-2030.
The neurological disease model chip market is a high-profile market segment in the biomedical field and has shown a rapid growth trend in recent years. With the deepening of neuroscience research and the continuous advancement of technology, more and more scientific research institutions and pharmaceutical companies have begun to pay attention to and invest in this field, promoting the expansion of the market scale. Neurological disease model chips are widely used in many fields such as neuroscience research, drug research and development, disease diagnosis and treatment. By simulating the structure and function of the nervous system, it can help researchers gain a deeper understanding of the pathogenesis of neurological diseases and find new treatments. In summary, the neurological disease model chip market has broad application prospects and huge market potential.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Neurological Disease Model Chip, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurological Disease Model Chip.
The Neurological Disease Model Chip market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Neurological Disease Model Chip market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurological Disease Model Chip manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Emulate
CN Bio
TissUse
AxoSim Technologies
Nortis
Mimetas
SynVivo
Axion Biosystems
Tara Biosystems
InSphero
Hesperos
Kugelmeiers
Ascendance Biotechnology
BioIVT
BGI Genomics
Segment by Type
Neuron Chip
Brain Chip
Brain Organ Chip
Segment by Application
Pharmaceutical R&D
Neuroscience Research
Clinical Diagnosis
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neurological Disease Model Chip manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neurological Disease Model Chip in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Neurological Disease Model Chip Market Overview
1.1 Product Definition
1.2 Neurological Disease Model Chip by Type
1.2.1 Global Neurological Disease Model Chip Market Value Comparison by Type (2024-2030)
1.2.2 Neuron Chip
1.2.3 Brain Chip
1.2.4 Brain Organ Chip
1.3 Neurological Disease Model Chip by Application
1.3.1 Global Neurological Disease Model Chip Market Value by Application (2024-2030)
1.3.2 Pharmaceutical R&D
1.3.3 Neuroscience Research
1.3.4 Clinical Diagnosis
1.4 Global Neurological Disease Model Chip Market Size Estimates and Forecasts
1.4.1 Global Neurological Disease Model Chip Revenue 2019-2030
1.4.2 Global Neurological Disease Model Chip Sales 2019-2030
1.4.3 Global Neurological Disease Model Chip Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neurological Disease Model Chip Market Competition by Manufacturers
2.1 Global Neurological Disease Model Chip Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neurological Disease Model Chip Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neurological Disease Model Chip Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Neurological Disease Model Chip, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neurological Disease Model Chip, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurological Disease Model Chip, Product Type & Application
2.7 Global Key Manufacturers of Neurological Disease Model Chip, Date of Enter into This Industry
2.8 Global Neurological Disease Model Chip Market Competitive Situation and Trends
2.8.1 Global Neurological Disease Model Chip Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Neurological Disease Model Chip Players Market Share by Revenue
2.8.3 Global Neurological Disease Model Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neurological Disease Model Chip Market Scenario by Region
3.1 Global Neurological Disease Model Chip Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neurological Disease Model Chip Sales by Region: 2019-2030
3.2.1 Global Neurological Disease Model Chip Sales by Region: 2019-2024
3.2.2 Global Neurological Disease Model Chip Sales by Region: 2025-2030
3.3 Global Neurological Disease Model Chip Revenue by Region: 2019-2030
3.3.1 Global Neurological Disease Model Chip Revenue by Region: 2019-2024
3.3.2 Global Neurological Disease Model Chip Revenue by Region: 2025-2030
3.4 North America Neurological Disease Model Chip Market Facts & Figures by Country
3.4.1 North America Neurological Disease Model Chip Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neurological Disease Model Chip Sales by Country (2019-2030)
3.4.3 North America Neurological Disease Model Chip Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neurological Disease Model Chip Market Facts & Figures by Country
3.5.1 Europe Neurological Disease Model Chip Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neurological Disease Model Chip Sales by Country (2019-2030)
3.5.3 Europe Neurological Disease Model Chip Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurological Disease Model Chip Market Facts & Figures by Region
3.6.1 Asia Pacific Neurological Disease Model Chip Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neurological Disease Model Chip Sales by Region (2019-2030)
3.6.3 Asia Pacific Neurological Disease Model Chip Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Neurological Disease Model Chip Market Facts & Figures by Country
3.7.1 Latin America Neurological Disease Model Chip Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neurological Disease Model Chip Sales by Country (2019-2030)
3.7.3 Latin America Neurological Disease Model Chip Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Neurological Disease Model Chip Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurological Disease Model Chip Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neurological Disease Model Chip Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neurological Disease Model Chip Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurological Disease Model Chip Sales by Type (2019-2030)
4.1.1 Global Neurological Disease Model Chip Sales by Type (2019-2024)
4.1.2 Global Neurological Disease Model Chip Sales by Type (2025-2030)
4.1.3 Global Neurological Disease Model Chip Sales Market Share by Type (2019-2030)
4.2 Global Neurological Disease Model Chip Revenue by Type (2019-2030)
4.2.1 Global Neurological Disease Model Chip Revenue by Type (2019-2024)
4.2.2 Global Neurological Disease Model Chip Revenue by Type (2025-2030)
4.2.3 Global Neurological Disease Model Chip Revenue Market Share by Type (2019-2030)
4.3 Global Neurological Disease Model Chip Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neurological Disease Model Chip Sales by Application (2019-2030)
5.1.1 Global Neurological Disease Model Chip Sales by Application (2019-2024)
5.1.2 Global Neurological Disease Model Chip Sales by Application (2025-2030)
5.1.3 Global Neurological Disease Model Chip Sales Market Share by Application (2019-2030)
5.2 Global Neurological Disease Model Chip Revenue by Application (2019-2030)
5.2.1 Global Neurological Disease Model Chip Revenue by Application (2019-2024)
5.2.2 Global Neurological Disease Model Chip Revenue by Application (2025-2030)
5.2.3 Global Neurological Disease Model Chip Revenue Market Share by Application (2019-2030)
5.3 Global Neurological Disease Model Chip Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Emulate
6.1.1 Emulate Company Information
6.1.2 Emulate Description and Business Overview
6.1.3 Emulate Neurological Disease Model Chip Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Emulate Neurological Disease Model Chip Product Portfolio
6.1.5 Emulate Recent Developments/Updates
6.2 CN Bio
6.2.1 CN Bio Company Information
6.2.2 CN Bio Description and Business Overview
6.2.3 CN Bio Neurological Disease Model Chip Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CN Bio Neurological Disease Model Chip Product Portfolio
6.2.5 CN Bio Recent Developments/Updates
6.3 TissUse
6.3.1 TissUse Company Information
6.3.2 TissUse Description and Business Overview
6.3.3 TissUse Neurological Disease Model Chip Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TissUse Neurological Disease Model Chip Product Portfolio
6.3.5 TissUse Recent Developments/Updates
6.4 AxoSim Technologies
6.4.1 AxoSim Technologies Company Information
6.4.2 AxoSim Technologies Description and Business Overview
6.4.3 AxoSim Technologies Neurological Disease Model Chip Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AxoSim Technologies Neurological Disease Model Chip Product Portfolio
6.4.5 AxoSim Technologies Recent Developments/Updates
6.5 Nortis
6.5.1 Nortis Company Information
6.5.2 Nortis Description and Business Overview
6.5.3 Nortis Neurological Disease Model Chip Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nortis Neurological Disease Model Chip Product Portfolio
6.5.5 Nortis Recent Developments/Updates
6.6 Mimetas
6.6.1 Mimetas Company Information
6.6.2 Mimetas Description and Business Overview
6.6.3 Mimetas Neurological Disease Model Chip Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mimetas Neurological Disease Model Chip Product Portfolio
6.6.5 Mimetas Recent Developments/Updates
6.7 SynVivo
6.7.1 SynVivo Company Information
6.7.2 SynVivo Description and Business Overview
6.7.3 SynVivo Neurological Disease Model Chip Sales, Revenue and Gross Margin (2019-2024)
6.7.4 SynVivo Neurological Disease Model Chip Product Portfolio
6.7.5 SynVivo Recent Developments/Updates
6.8 Axion Biosystems
6.8.1 Axion Biosystems Company Information
6.8.2 Axion Biosystems Description and Business Overview
6.8.3 Axion Biosystems Neurological Disease Model Chip Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Axion Biosystems Neurological Disease Model Chip Product Portfolio
6.8.5 Axion Biosystems Recent Developments/Updates
6.9 Tara Biosystems
6.9.1 Tara Biosystems Company Information
6.9.2 Tara Biosystems Description and Business Overview
6.9.3 Tara Biosystems Neurological Disease Model Chip Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Tara Biosystems Neurological Disease Model Chip Product Portfolio
6.9.5 Tara Biosystems Recent Developments/Updates
6.10 InSphero
6.10.1 InSphero Company Information
6.10.2 InSphero Description and Business Overview
6.10.3 InSphero Neurological Disease Model Chip Sales, Revenue and Gross Margin (2019-2024)
6.10.4 InSphero Neurological Disease Model Chip Product Portfolio
6.10.5 InSphero Recent Developments/Updates
6.11 Hesperos
6.11.1 Hesperos Company Information
6.11.2 Hesperos Description and Business Overview
6.11.3 Hesperos Neurological Disease Model Chip Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hesperos Neurological Disease Model Chip Product Portfolio
6.11.5 Hesperos Recent Developments/Updates
6.12 Kugelmeiers
6.12.1 Kugelmeiers Company Information
6.12.2 Kugelmeiers Description and Business Overview
6.12.3 Kugelmeiers Neurological Disease Model Chip Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Kugelmeiers Neurological Disease Model Chip Product Portfolio
6.12.5 Kugelmeiers Recent Developments/Updates
6.13 Ascendance Biotechnology
6.13.1 Ascendance Biotechnology Company Information
6.13.2 Ascendance Biotechnology Description and Business Overview
6.13.3 Ascendance Biotechnology Neurological Disease Model Chip Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Ascendance Biotechnology Neurological Disease Model Chip Product Portfolio
6.13.5 Ascendance Biotechnology Recent Developments/Updates
6.14 BioIVT
6.14.1 BioIVT Company Information
6.14.2 BioIVT Description and Business Overview
6.14.3 BioIVT Neurological Disease Model Chip Sales, Revenue and Gross Margin (2019-2024)
6.14.4 BioIVT Neurological Disease Model Chip Product Portfolio
6.14.5 BioIVT Recent Developments/Updates
6.15 BGI Genomics
6.15.1 BGI Genomics Company Information
6.15.2 BGI Genomics Description and Business Overview
6.15.3 BGI Genomics Neurological Disease Model Chip Sales, Revenue and Gross Margin (2019-2024)
6.15.4 BGI Genomics Neurological Disease Model Chip Product Portfolio
6.15.5 BGI Genomics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurological Disease Model Chip Industry Chain Analysis
7.2 Neurological Disease Model Chip Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurological Disease Model Chip Production Mode & Process
7.4 Neurological Disease Model Chip Sales and Marketing
7.4.1 Neurological Disease Model Chip Sales Channels
7.4.2 Neurological Disease Model Chip Distributors
7.5 Neurological Disease Model Chip Customers
8 Neurological Disease Model Chip Market Dynamics
8.1 Neurological Disease Model Chip Industry Trends
8.2 Neurological Disease Model Chip Market Drivers
8.3 Neurological Disease Model Chip Market Challenges
8.4 Neurological Disease Model Chip Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Neurological Disease Model Chip Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Neurological Disease Model Chip Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Neurological Disease Model Chip Market Competitive Situation by Manufacturers in 2023
Table 4. Global Neurological Disease Model Chip Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Neurological Disease Model Chip Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Neurological Disease Model Chip Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Neurological Disease Model Chip Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Neurological Disease Model Chip Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Neurological Disease Model Chip, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Neurological Disease Model Chip, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neurological Disease Model Chip, Product Type & Application
Table 12. Global Key Manufacturers of Neurological Disease Model Chip, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neurological Disease Model Chip by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Disease Model Chip as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neurological Disease Model Chip Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Neurological Disease Model Chip Sales by Region (2019-2024) & (K Units)
Table 18. Global Neurological Disease Model Chip Sales Market Share by Region (2019-2024)
Table 19. Global Neurological Disease Model Chip Sales by Region (2025-2030) & (K Units)
Table 20. Global Neurological Disease Model Chip Sales Market Share by Region (2025-2030)
Table 21. Global Neurological Disease Model Chip Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Neurological Disease Model Chip Revenue Market Share by Region (2019-2024)
Table 23. Global Neurological Disease Model Chip Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Neurological Disease Model Chip Revenue Market Share by Region (2025-2030)
Table 25. North America Neurological Disease Model Chip Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 27. North America Neurological Disease Model Chip Sales by Country (2025-2030) & (K Units)
Table 28. North America Neurological Disease Model Chip Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Neurological Disease Model Chip Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Neurological Disease Model Chip Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 32. Europe Neurological Disease Model Chip Sales by Country (2025-2030) & (K Units)
Table 33. Europe Neurological Disease Model Chip Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Neurological Disease Model Chip Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Neurological Disease Model Chip Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Neurological Disease Model Chip Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Neurological Disease Model Chip Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Neurological Disease Model Chip Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Neurological Disease Model Chip Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Neurological Disease Model Chip Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Neurological Disease Model Chip Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Neurological Disease Model Chip Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Neurological Disease Model Chip Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Neurological Disease Model Chip Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Neurological Disease Model Chip Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Neurological Disease Model Chip Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Neurological Disease Model Chip Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Neurological Disease Model Chip Sales (K Units) by Type (2019-2024)
Table 51. Global Neurological Disease Model Chip Sales (K Units) by Type (2025-2030)
Table 52. Global Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
Table 53. Global Neurological Disease Model Chip Sales Market Share by Type (2025-2030)
Table 54. Global Neurological Disease Model Chip Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Neurological Disease Model Chip Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Neurological Disease Model Chip Revenue Market Share by Type (2019-2024)
Table 57. Global Neurological Disease Model Chip Revenue Market Share by Type (2025-2030)
Table 58. Global Neurological Disease Model Chip Price (US$/Unit) by Type (2019-2024)
Table 59. Global Neurological Disease Model Chip Price (US$/Unit) by Type (2025-2030)
Table 60. Global Neurological Disease Model Chip Sales (K Units) by Application (2019-2024)
Table 61. Global Neurological Disease Model Chip Sales (K Units) by Application (2025-2030)
Table 62. Global Neurological Disease Model Chip Sales Market Share by Application (2019-2024)
Table 63. Global Neurological Disease Model Chip Sales Market Share by Application (2025-2030)
Table 64. Global Neurological Disease Model Chip Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Neurological Disease Model Chip Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Neurological Disease Model Chip Revenue Market Share by Application (2019-2024)
Table 67. Global Neurological Disease Model Chip Revenue Market Share by Application (2025-2030)
Table 68. Global Neurological Disease Model Chip Price (US$/Unit) by Application (2019-2024)
Table 69. Global Neurological Disease Model Chip Price (US$/Unit) by Application (2025-2030)
Table 70. Emulate Company Information
Table 71. Emulate Description and Business Overview
Table 72. Emulate Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Emulate Neurological Disease Model Chip Product
Table 74. Emulate Recent Developments/Updates
Table 75. CN Bio Company Information
Table 76. CN Bio Description and Business Overview
Table 77. CN Bio Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. CN Bio Neurological Disease Model Chip Product
Table 79. CN Bio Recent Developments/Updates
Table 80. TissUse Company Information
Table 81. TissUse Description and Business Overview
Table 82. TissUse Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. TissUse Neurological Disease Model Chip Product
Table 84. TissUse Recent Developments/Updates
Table 85. AxoSim Technologies Company Information
Table 86. AxoSim Technologies Description and Business Overview
Table 87. AxoSim Technologies Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. AxoSim Technologies Neurological Disease Model Chip Product
Table 89. AxoSim Technologies Recent Developments/Updates
Table 90. Nortis Company Information
Table 91. Nortis Description and Business Overview
Table 92. Nortis Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Nortis Neurological Disease Model Chip Product
Table 94. Nortis Recent Developments/Updates
Table 95. Mimetas Company Information
Table 96. Mimetas Description and Business Overview
Table 97. Mimetas Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Mimetas Neurological Disease Model Chip Product
Table 99. Mimetas Recent Developments/Updates
Table 100. SynVivo Company Information
Table 101. SynVivo Description and Business Overview
Table 102. SynVivo Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. SynVivo Neurological Disease Model Chip Product
Table 104. SynVivo Recent Developments/Updates
Table 105. Axion Biosystems Company Information
Table 106. Axion Biosystems Description and Business Overview
Table 107. Axion Biosystems Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Axion Biosystems Neurological Disease Model Chip Product
Table 109. Axion Biosystems Recent Developments/Updates
Table 110. Tara Biosystems Company Information
Table 111. Tara Biosystems Description and Business Overview
Table 112. Tara Biosystems Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Tara Biosystems Neurological Disease Model Chip Product
Table 114. Tara Biosystems Recent Developments/Updates
Table 115. InSphero Company Information
Table 116. InSphero Description and Business Overview
Table 117. InSphero Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. InSphero Neurological Disease Model Chip Product
Table 119. InSphero Recent Developments/Updates
Table 120. Hesperos Company Information
Table 121. Hesperos Description and Business Overview
Table 122. Hesperos Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Hesperos Neurological Disease Model Chip Product
Table 124. Hesperos Recent Developments/Updates
Table 125. Kugelmeiers Company Information
Table 126. Kugelmeiers Description and Business Overview
Table 127. Kugelmeiers Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Kugelmeiers Neurological Disease Model Chip Product
Table 129. Kugelmeiers Recent Developments/Updates
Table 130. Ascendance Biotechnology Company Information
Table 131. Ascendance Biotechnology Description and Business Overview
Table 132. Ascendance Biotechnology Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Ascendance Biotechnology Neurological Disease Model Chip Product
Table 134. Ascendance Biotechnology Recent Developments/Updates
Table 135. BioIVT Company Information
Table 136. BioIVT Description and Business Overview
Table 137. BioIVT Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. BioIVT Neurological Disease Model Chip Product
Table 139. BioIVT Recent Developments/Updates
Table 140. BGI Genomics Company Information
Table 141. BGI Genomics Description and Business Overview
Table 142. BGI Genomics Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. BGI Genomics Neurological Disease Model Chip Product
Table 144. BGI Genomics Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Neurological Disease Model Chip Distributors List
Table 148. Neurological Disease Model Chip Customers List
Table 149. Neurological Disease Model Chip Market Trends
Table 150. Neurological Disease Model Chip Market Drivers
Table 151. Neurological Disease Model Chip Market Challenges
Table 152. Neurological Disease Model Chip Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report


List of Figures
Figure 1. Product Picture of Neurological Disease Model Chip
Figure 2. Global Neurological Disease Model Chip Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Neurological Disease Model Chip Market Share by Type: 2023 & 2030
Figure 4. Neuron Chip Product Picture
Figure 5. Brain Chip Product Picture
Figure 6. Brain Organ Chip Product Picture
Figure 7. Global Neurological Disease Model Chip Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Neurological Disease Model Chip Market Share by Application: 2023 & 2030
Figure 9. Pharmaceutical R&D
Figure 10. Neuroscience Research
Figure 11. Clinical Diagnosis
Figure 12. Global Neurological Disease Model Chip Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Neurological Disease Model Chip Market Size (2019-2030) & (US$ Million)
Figure 14. Global Neurological Disease Model Chip Sales (2019-2030) & (K Units)
Figure 15. Global Neurological Disease Model Chip Average Price (US$/Unit) & (2019-2030)
Figure 16. Neurological Disease Model Chip Report Years Considered
Figure 17. Neurological Disease Model Chip Sales Share by Manufacturers in 2023
Figure 18. Global Neurological Disease Model Chip Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Neurological Disease Model Chip Players: Market Share by Revenue in Neurological Disease Model Chip in 2023
Figure 20. Neurological Disease Model Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Neurological Disease Model Chip Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Neurological Disease Model Chip Sales Market Share by Country (2019-2030)
Figure 23. North America Neurological Disease Model Chip Revenue Market Share by Country (2019-2030)
Figure 24. United States Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Neurological Disease Model Chip Sales Market Share by Country (2019-2030)
Figure 27. Europe Neurological Disease Model Chip Revenue Market Share by Country (2019-2030)
Figure 28. Germany Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Neurological Disease Model Chip Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Neurological Disease Model Chip Revenue Market Share by Region (2019-2030)
Figure 35. China Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Neurological Disease Model Chip Sales Market Share by Country (2019-2030)
Figure 43. Mexico Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Neurological Disease Model Chip Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Neurological Disease Model Chip Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Neurological Disease Model Chip Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Neurological Disease Model Chip by Type (2019-2030)
Figure 53. Global Revenue Market Share of Neurological Disease Model Chip by Type (2019-2030)
Figure 54. Global Neurological Disease Model Chip Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Neurological Disease Model Chip by Application (2019-2030)
Figure 56. Global Revenue Market Share of Neurological Disease Model Chip by Application (2019-2030)
Figure 57. Global Neurological Disease Model Chip Price (US$/Unit) by Application (2019-2030)
Figure 58. Neurological Disease Model Chip Value Chain
Figure 59. Neurological Disease Model Chip Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock